shim
shim signature
shim


   KLARICID GRANULES

   KLARICID IV

   KLARICID TABLETS

   KLARICID XL




















 







.
KLARICID GRANULES

Ingredient(s): Each 5ml teaspoonful contains: Clarithromycin USP 125 mg
Indications: Klaricid Granules is indicated for treatment of infections due to susceptible organisms, in the following conditions:
  • Upper respiratory infections (e.g., streptococcal pharyngitis).
  • Lower respiratory infections (e.g., bronchitis, pneumonia).
  • Acute otitis media.
  • Skin and skin structure infections (e.g., impetigo, folliculitis, cellulitis, abscesses).
  • Disseminated or localized mycobacterial infections due to Mycobacterium avium or Mycobacterium intracellulare. Localized infections due to Mycobacterium chelonae, Mycobacterium fortuitum, or Mycobacterium kansasii.

Pack Size:    60ml bottle in carton
Top of Page

 







.
KLARICID IV

Ingredient(s): Klaricid I.V., is a lyophilized powder containing clarithromycin lactobionate equivalent to 500 mg clarithromycin per vial.
Indications: Klaricid I.V. is indicated whenever parenteral therapy is required for treatment of sensitive microorganisms in the following conditions:
  • Upper respiratory tract infections
  • Lower respiratory tract infections
  • Skin and soft tissue infections
  • Disseminated or localized mycobacterial infections due to Mycobacterium avium or Mycobacterium intracellulare. Localized infections due to Mycobacterium chelonae, Mycobacterium fortuitum, or Mycobacterium kansasii.

Pack Size:    1 vial in carton
Top of Page

 







.
KLARICID TABLETS

Ingredient(s):
Each Klaricid 250 mg Tablet contains: Clarithromycin 250 mg
Each Klaricid 500 mg Tablet contains: Clarithromycin 500 mg
Indications: Klaricid is indicated for treatment of infections due to susceptible organisms. Such infections include:
  • Lower respiratory tract infections (e.g., bronchitis, pneumonia);
  • Upper respiratory tract infections (e.g., pharyngitis, sinusitis);
  • Skin and soft tissue infections (e.g., folliculitis, cellulitis, erysipelas);
  • Disseminated or localized mycobacterial infections due to Mycobacterium avium or Mycobacterium intracellulare. Localized infections due to Mycobacterium chelonae, Mycobacterium fortuitum, or Mycobacterium kansasii;
  • Clarithromycin is indicated for the prevention of disseminated Mycobacterium avium complex infection in HIV-infected patients with CD4 lymphocyte counts less than or equal to 100/mm3;
  • Clarithromycin in the presence of acid suppression is also indicated for the eradication of H. pylori resulting in decreased recurrence of duodenal ulcer
  • Treatment of odontogenic infections

Pack Size:    1x10s in carton
Top of Page

 







.
KLARICID XL

Ingredient(s):
Each Klaricid XL (modified release tablet) contains: Clarithromycin 500 mg .
Indications: Klaricid XL is indicated for treatment of :
  • Lower respiratory tract infections (e.g., bronchitis, pneumonia),
  • Upper respiratory tract infections (e.g., pharyngitis, sinusitis), and
  • Skin and soft tissue infections (e.g., folliculitis, cellulitis, erysipelas).

Pack Size:    5s in carton
Top of Page






shim
shim
shim Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company.